Researchers
Division of Fostering Required Medical Human Resources
Divisional Director
Divisional Director
MORII Eiichi
Status : Prof.
Research Field : Experimental pathology,Human pathology
Profile
Graduated from Kyoto Univ Faculty of Pharmaceutical Science, and graduated from Osaka University Medical School. After graduation, I have consistently conducted pathological research and pathological diagnosis, including infectious disease education and infectious disease research. As the chair of the pathology specialist system steering committee at the Japanese Society of Pathology, I am also working to improve the Japanese specialist system for Diagnostic and Molecular Pathology.
Research Activities
・Analysis of tumor heterogeneity and its regulatory system, Relation to Infectious Disease.
Publications
1. Ohshima K, Morii E. (2021). Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis. Metabolites. 11, 28.
2. Kusumoto S, et al. (2021). An immature inhibin-α-expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis. Cancer Med. 10, 1485.
3. Ohshima K, et al. (2020). Serine racemase enhances growth of colorectal cancer by producing pyruvate from serine. Nat Metab. 2, 81.
4. Kawasaki K, et al. (2020). FAM111B enhances proliferation of KRAS-driven lung adenocarcinoma by degrading p16. Cancer Sci. 111, 2635.
5. Tone M, et al. (2020). HTR3A is correlated with unfavorable histology and promotes proliferation through ERK phosphorylation in lung adenocarcinoma. Cancer Sci. 111, 3953.
